Week beginning 7th October 2024
News, articles and advocacy
USA Open Access Government Creating a Research Home for ME/CFS, Long Covid, and others"
Op-ed by Emily Taylor, President and CEO of Solve M.E on the importance of more research into infection-associated chronic conditions and illnesses.
Oped (p. 40-41) l
Thread
ContagionLive "Unmasking Long Covid Through Understanding Prevalence and Diagnosis"
A Long COVID roundtable which is a collaborative project from ContagionLive and NeurologyLive.
'In this first episode, clinicians discuss the prevalence of Long COVID, its underestimation due to subclinical cases and recruitment challenges, and stress the importance of thorough history-taking for accurate diagnosis, especially regarding its overlap with ME/CFS..'
Episode l
Thread
New Zealand
A feature article in three parts by newsroom on Long Covid in New Zealand.
Part one: 'Long Covid sufferers' quality of life close to MS patients'.
Part two: 'Kiwis with Long Covid speak out'
Part three: 'Government's head in the sand on Long Covid'
Thread
USA ANCC (American Nurses Credentialing Center) and Sigma have rewarded the project "Community Insight to Clinical Care: A Nursing-Led Evidence Based Patient Education Program for ME/CFS" as recipient of the Sigma/ANCC Evidence-Based Practice Implementation Grant. The team behind the project includes Jessica Ask, MSN, RN, Stephanie Grach, MS,MD and Jamie Seltzer, MS, and is led by Nisha Mathews, PhD, MSN, RN. "This nursing-led project addresses the critical need for enhanced patient education in managing ME/CFS, a condition affecting millions globally, particularly in the wake of long COVID-19."
Article l
Thread
USA Mount Sinai Opens State-of-the-Art Center for Patients With Complex Conditions Including Lyme Disease and Long COVID
David Putrino comments: "Our Center will be one of the few places in the world embedded in a major clinical institution that's able to provide outstanding care management as well as leading-edge research focused on biological discovery".
Article l
Thread
Germany
Christian Zacharias, a German patient with ME/CFS, has published a book titled "Everything is psychosomatic". It covers ME/CFS and Long Covid, the plight of those affected, their fight for research and education, the sabotage by some doctors and the sluggish reaction of politicians.
Article |
Thread
.........
UK inquest
Prevention of Future Deaths Report
Following the recent inquest into the death of Maeve Boothby O’Neill, the coroner, Deborah Archer, has written a Regulation 28 Prevention of Future Deaths Report.
Report
The Times Coroner demands urgent action to prevent further deaths from ME
"Deborah Archer, who concluded in the summer that Boothby O’Neill, 27, died of malnutrition as a result of ME, has called on Wes Streeting, NHS officials and other health bodies to take urgent action. She wrote in a Regulation 28 report: “During the course of the inquest the evidence revealed matters giving rise to concern. In my opinion there is a risk that future deaths could occur unless action is taken.”"
Article |
Archived version |
Thread
Further coverage:
The Times |
The Times letter |
The Guardian |
The Guardian editorial |
The Telegraph |
Daily Mail |
BBC Devon
BBC World Tonight (5 min) |
Times Radio (6 min) |
BBC Breakfast
BBC Radio 4 Today (4.5 min) |
Sky News (11 min)
The BMJ Care for people with severe ME is “nonexistent,” says coroner in call to action (paywalled)
BBC 'I'm too tired to chew food but still can't get care for my ME'
Trial by Error by David Tuller A summary of the news coverage of the Coroner's report with the observation that "journalists covering the issue have generally accepted at face value the notion that ME is serious disease with potentially fatal consequences".
.............
Crowdfunding
Trial by Error October Crowdfunding Campaign
New round of crowdfunding to support David Tuller's important work on reporting on ME, ME/CFS, Long Covid, and "Medically Unexplained Symptoms". The goal is to reach $67,000 on UC Berkeley's platform by the end of October to secure Tuller's position for another six months.
Crowdfunding l
Thread
.............
Coming Events
UK Action for ME Genetics Centre of Excellence webinar
24 October, from 2 to 3 pm hosted by AfME, speakers include Prof Chris Ponting, Prof Simon Carding and Dr Audrey Ryback, plus Q&A session.
Details and registration |
Thread
...............
Research
ME/CFS research
Neuromuscular Disorders
Conference abstract: 571P Muscular metabolic plasticity in 3D in vitro models against systemic stress factors in ME/CFS and long COVID-19 - Mughal et al.
In vitro muscle tissue was exposed to patients' sera.
"The analyses revealed an upregulation of glycolytic enzymes especially of PDK4, suggesting a switch away from Oxidative Phosphorylation as well as a decline in DRP1, involved in mitochondrial fission."
Abstract |
Thread
Journal of Translational Medicine
Immunometabolic changes and potential biomarkers in CFS peripheral immune cells revealed by single-cell RNA sequencing - Sun et al
Used a small sample to study blood cells. "The results support a disease model of immune dysfunction ranging from autoimmunity to immunodeficiency and point to amyloidotic neurodegenerative signaling pathways in the pathogenesis of ME/CFS."
Article |
Thread
COVID
Development of an ME/CFS Online Screener - Cathey & Jason
This study describes a new online screener that can be completed by individuals who might like to determine if they meet the current ME/CFS criteria.
Article |
Thread
Respiratory Physiology & Neurobiology
Inspiratory muscle training improves autonomic function in myalgic encephalomyelitis/chronic fatigue syndrome and post-acute sequelae of SARS-CoV-2: A pilot study - Edgall et al.
The authors conducted a small clinical trial of inspiratory muscle training in patients with Long Covid and ME/CFS to improve their autonomic function.
Article |
Thread
Long Covid research
Clinical Microbiology and Infection
Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study — Zoe Swank et al.
"The findings of this multicohort study indicate that SARS-CoV-2 antigens can be detected in the blood of a substantial proportion of individuals up to 14 months after infection. While approximately one in five asymptomatic individuals was antigen-positive, roughly half of all individuals reporting ongoing cardiopulmonary, musculoskeletal, and neurologic symptoms were antigen-positive."
Article |
Thread
Brain
Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations — Rua et al.
"Our key findings were that in COVID-19 survivors, multiple regions of the medulla oblongata, pons and midbrain show magnetic resonance susceptibility abnormalities at a median time of 6.5 months from hospital admission. These differences are consistent with a neuroinflammatory response."
Article |
Thread
American Journal of Neuroradiology
Macro- and Microstructural White Matter Differences in Neurologic Postacute Sequelae of SARS-CoV-2 Infection — Erin E. O’Connor et al.
"NeuroPASC participants have larger WM volumes than NoCOVID controls and these larger WM volumes are associated with higher PASC scores and greater psychometric deficits. The WM effects may be related to neuroinflammation, with attendant inflammatory microstructural changes and extracellular fluid shifts, a conjecture that can be confirmed with further studies employing free water measures obtained by using multi shell diffusion and myelin water imaging."
Article |
Thread
Arteriosclerosis, Thrombosis, and Vascular Biology
COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type — James R. Hilser et al.
"Taken together, our data indicate that the elevated risk of [major adverse cardiac event] in COVID-19 patients shows no apparent signs of attenuation up to nearly 3 years after SARS-CoV-2 infection and suggest that COVID-19 continues to pose a significant public health burden with lingering adverse cardiovascular risk."
Article |
Thread
Preprint: MedRxiv
Multi-ancestry GWAS of Long COVID identifies immune-related loci and etiological links to chronic fatigue syndrome, fibromyalgia and depression — Ninad S Chaudhary et al.
"GWAS of Long COVID identified three genome-wide significant loci (HLA-DQA1 and HLA-DQB, ABO, BPTF:KPAN2:C17orf58). Functional analysis of these genes points to underlying immune and thrombo-inflammatory mechanisms."
Article |
Thread
JAMA Network Open
Post–COVID-19 Condition Fatigue Outcomes Among Danish Residents — Elisabeth O’Regan et al.
"a 3% increase in self-reported fatigue and 2-fold increase in symptoms of postexertional malaise were found 2 to 18 months after infection" "Preexisting psychiatric conditions did not significantly modify the risk of postacute fatigue symptoms."
Article |
Thread
BMC Infectious Diseases
Post-viral symptoms and conditions are more frequent in COVID-19 than influenza, but not more persistent — Tesch et al.
"The main contributions in terms of absolute excess risk came from dyspnea and malaise/ exhaustion, while the highest IRR was observed for chronic fatigue syndrome. After one year, only a minority of the initial patients still suffer from post-COVID condition with a similar pattern of persistence among patients with influenza."
Article |
Thread
Women's Health Reports
Endometriosis Patients Have an Increased Risk of Experiencing Long-Covid Symptoms: Results from a Cross-Sectional Multicenter Study — Anna Cirkel et al.
"Subjects with [surgically confirmed endometriosis] had a twofold increased risk of LC (in comparison to subjects with nonconfirmed endometriosis menstrual pain)."
Article |
Thread
ERJ Open Research
A new phenotype of patients with post-COVID-19 condition is characterised by a pattern of complex ventilatory dysfunction, neuromuscular disturbance and fatigue symptoms — Fridolin Steinbeis et al.
"Dyspnoea in PCF is characterised by reduced respiratory muscle strength and complex ventilatory dysfunction indicating neuromuscular disturbance as a distinct phenotype among patients with post-COVID-19 condition."
Article |
Thread
Brain, Behavior, and Immunity
A review of intravenous immunoglobulin in the treatment of neuroimmune conditions, acute COVID-19 infection, and post-acute sequelae of COVID-19 Syndrome — Morse et al.
"Although IVIG has been proposed as a viable treatment for PASC, present studies exploring its efficacy are lacking."
Article |
Thread
..............
S4ME social media:
Forum,
Facebook,
Twitter,
Mastodon,
Bluesky and
YouTube